ADT对前列腺癌伴CVD患者的心血管作用研究进展  

Cardiovascular side effects of androgen deprivation therapy in prostate cancer patients with CVD

作　　者：秦子家 尹思文 何卫阳(审校)[1] QIN Zijia;YIN Siwen;HE Weiyang(Department of Urology,First Affiliated Hospital of Chongqing Medical University,Chongqing,400016,China)

机构地区：[1]重庆医科大学附属第一医院泌尿外科,重庆400016

出　　处：《临床泌尿外科杂志》2022年第10期796-799,805,共5页Journal of Clinical Urology

摘　　要：前列腺癌是全世界男性最常见的恶性肿瘤之一。目前前列腺癌的治疗方法主要包括手术、放疗、化疗以及内分泌治疗。雄激素剥脱治疗(androgen deprivation therapy,ADT)作为进展期前列腺癌的一线治疗方案,近年来陆续有文献报道其增加了患者死于心血管病的风险。本文拟对ADT方案及它们的心血管不良反应作一综述。Prostate cancer is one of the most prevalent malignant tumors in man around the world.Its therapeutic schemes include radical prostatectomy,radiotherapy,chemotherapy and endocrine therapy.Androgen deprivation therapy(ADT)is the first-line adjuvant therapy option for patients with advanced prostate cancer.However,ADT has been reported to be responsible for some cardiovascular deaths in patients.In this article,various ADT options and their corresponding cardiovascular side effects are summarized as follows.

关 键 词：前列腺癌 雄激素剥脱治疗 心血管不良反应 

分 类 号：R737.25[医药卫生—肿瘤]